Chinese biopharmaceutical firm Jixing bags $162m Series D round
Jixing Pharmaceutical has pocketed a combined $162 million from Germany's Bayer and New York-based investment firm RTW Investments.
Source: dealstreetasia.com
Xiaolan Zhou News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Xiaolan Zhou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Xiaolan Zhou Today - Breaking & Trending Today
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Source: pharmiweb.com
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Germany - Bayer and RTW Investments, LP today announced an equity investment into Ji Xing Pharmaceuticals Limited in the amount of USD 35 million and USD 127 million respectively. JIXING, founded...
Source: marketscreener.com
Chinese company sees approval for diabetes drug
Hua Medicine says its new drug application for HuaTangNing has been approved by the National Medical Products Administration in China.
Source: labiotech.eu